AbbVie to Invest $380 Million in North Chicago to Further Expand Active Pharmaceutical Ingredient Manufacturing in the United States.
Published: 06 Apr 2026
Author: Towards Healthcare
AbbVie has announced a significant investment of $ 380 million to build two new active pharmaceutical ingredient (API) manufacturing facilities in North Chicago, Illinois.
These new state-of-the-art facilities will integrate advanced manufacturing technologies with new trending Artificial Intelligence to support the production of next-generation neuroscience and obesity medications.
Market growth is driven by Pharmaceutical Ingredient (API) production.
According to Towards Healthcare, the Pharmaceutical manufacturing Market is projected to experience significant growth, with estimates suggesting the market size will increase from USD 652.67 billion in 2026 to approximately USD 1095.2 billion by 2035, representing a compound annual growth rate (CAGR) of 5.92% from 2026 to 2035. Growth is driven by its innovative product and strategic investment, which support its overall revenue growth while maintaining high R&D investment. The company has demonstrated resilience, continuing to expand its pipeline and strengthen its global net revenue.
With a presence in all 50 states and Puerto Rico, AbbVie employs approximately 29,000 people in the U.S., including more than 6,000 at its U.S. manufacturing sites. This investment helps to advance AbbVie's long-term commitment to Illinois, where it is headquartered and employs more than 11,500 people.
AbbVie in API Production
The U.S. government is putting effort into aligning investment in API production to encourage domestic production and manufacturing capabilities, and lowering prescription drug prices. Expansion is the part to support next-generation neuroscience and obesity medication, expected to be operational in 2029.
Chairman and chief executive officer, AbbVie, Robert A. Michael, said This milestone demonstrates further progress against our $100 billion commitment to U.S. R&D and capital investments over the next decade.
About AbbVie
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first for patients, communities, and our world.
AbbVie's remarkable mission is to discover and deliver innovative medicines and solutions that solve serious health issues and address the medical challenges of tomorrow. Company aims to address complex health issues and enhance people's lives through our core therapeutic areas - immunology, oncology, neuroscience, eye care, aesthetics, and other areas of unmet need.
A recent report by Towards Healthcare highlights that the Pharmaceutical manufacturing market is focusing on innovative treatment for complex health challenges and make real difference in people's lives through its therapeutic areas - immunology, oncology, neuroscience, eye care, and aesthetics.